Annual SGA
$12.24 M
+$585.00 K+5.02%
December 31, 2023
Summary
- As of February 22, 2025, CMPX annual SGA is $12.24 million, with the most recent change of +$585.00 thousand (+5.02%) on December 31, 2023.
- During the last 3 years, CMPX annual SGA has fallen by -$665.00 thousand (-5.15%).
- CMPX annual SGA is now -5.15% below its all-time high of $12.91 million, reached on December 1, 2020.
Performance
CMPX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$3.63 M
-$1.09 M-23.17%
September 1, 2024
Summary
- As of February 22, 2025, CMPX quarterly SGA is $3.63 million, with the most recent change of -$1.09 million (-23.17%) on September 1, 2024.
- Over the past year, CMPX quarterly SGA has increased by +$379.00 thousand (+11.67%).
- CMPX quarterly SGA is now -31.45% below its all-time high of $5.29 million, reached on September 1, 2020.
Performance
CMPX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.33 B
-$47.76 M-3.72%
September 1, 2024
Summary
- As of February 22, 2025, CMPX TTM SGA is -$1.33 billion, with the most recent change of -$47.76 million (-3.72%) on September 1, 2024.
- Over the past year, CMPX TTM SGA has dropped by -$1.34 billion (-10806.91%).
- CMPX TTM SGA is now -991.17% below its all-time high of -$121.91 million.
Performance
CMPX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CMPX Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +5.0% | +11.7% | -10000.0% |
3 y3 years | -5.2% | +11.7% | -10000.0% |
5 y5 years | +9.2% | +11.7% | -10000.0% |
CMPX Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +12.0% | -23.2% | +31.1% | -60.7% | at low |
5 y | 5-year | -5.2% | +12.0% | -31.4% | +74.0% | -991.2% | at low |
alltime | all time | -5.2% | +12.0% | -31.4% | +74.0% | -991.2% | at low |
Compass Therapeutics Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $3.63 M(-23.2%) | $14.56 M(+3.8%) |
Jun 2024 | - | $4.72 M(+45.4%) | $14.03 M(+12.9%) |
Mar 2024 | - | $3.25 M(+9.5%) | $12.42 M(+1.4%) |
Dec 2023 | $12.24 M(+5.0%) | $2.97 M(-4.1%) | $12.25 M(+0.1%) |
Sep 2023 | - | $3.10 M(-0.6%) | $12.24 M(+2.4%) |
Jun 2023 | - | $3.11 M(+1.3%) | $11.95 M(-0.1%) |
Mar 2023 | - | $3.07 M(+3.8%) | $11.96 M(+2.6%) |
Dec 2022 | $11.66 M(+6.7%) | $2.96 M(+5.5%) | $11.66 M(-3.9%) |
Sep 2022 | - | $2.81 M(-10.2%) | $12.13 M(+0.9%) |
Jun 2022 | - | $3.13 M(+12.9%) | $12.02 M(+8.7%) |
Mar 2022 | - | $2.77 M(-19.3%) | $11.06 M(+1.2%) |
Dec 2021 | $10.93 M | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | - | $3.43 M(+26.9%) | $10.93 M(-1.1%) |
Sep 2021 | - | $2.70 M(+24.7%) | $11.04 M(-19.0%) |
Jun 2021 | - | $2.17 M(-17.8%) | $13.64 M(+0.6%) |
Mar 2021 | - | $2.63 M(-25.6%) | $13.55 M(+2.8%) |
Dec 2020 | $12.91 M(+11.2%) | $3.54 M(-33.0%) | $13.18 M(+3.5%) |
Sep 2020 | - | $5.29 M(+153.8%) | $12.73 M(+29.3%) |
Jun 2020 | - | $2.08 M(-7.7%) | $9.85 M(-10.9%) |
Mar 2020 | - | $2.26 M(-27.1%) | $11.05 M(+25.7%) |
Dec 2019 | $11.60 M(+3.4%) | $3.10 M(+28.9%) | $8.79 M(+54.5%) |
Sep 2019 | - | $2.40 M(-26.8%) | $5.69 M(+73.2%) |
Jun 2019 | - | $3.28 M | $3.28 M |
Dec 2018 | $11.22 M | - | - |
FAQ
- What is Compass Therapeutics annual SGA?
- What is the all time high annual SGA for Compass Therapeutics?
- What is Compass Therapeutics annual SGA year-on-year change?
- What is Compass Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Compass Therapeutics?
- What is Compass Therapeutics quarterly SGA year-on-year change?
- What is Compass Therapeutics TTM SGA?
- What is the all time high TTM SGA for Compass Therapeutics?
- What is Compass Therapeutics TTM SGA year-on-year change?
What is Compass Therapeutics annual SGA?
The current annual SGA of CMPX is $12.24 M
What is the all time high annual SGA for Compass Therapeutics?
Compass Therapeutics all-time high annual SGA is $12.91 M
What is Compass Therapeutics annual SGA year-on-year change?
Over the past year, CMPX annual SGA has changed by +$585.00 K (+5.02%)
What is Compass Therapeutics quarterly SGA?
The current quarterly SGA of CMPX is $3.63 M
What is the all time high quarterly SGA for Compass Therapeutics?
Compass Therapeutics all-time high quarterly SGA is $5.29 M
What is Compass Therapeutics quarterly SGA year-on-year change?
Over the past year, CMPX quarterly SGA has changed by +$379.00 K (+11.67%)
What is Compass Therapeutics TTM SGA?
The current TTM SGA of CMPX is -$1.33 B
What is the all time high TTM SGA for Compass Therapeutics?
Compass Therapeutics all-time high TTM SGA is -$121.91 M
What is Compass Therapeutics TTM SGA year-on-year change?
Over the past year, CMPX TTM SGA has changed by -$1.34 B (-10806.91%)